Norway· NO-ID_B695CA82-7F36-4931-BCD7-40724264BA02
Firmagon
A degarelix product containing degarelix, registered in Norway by Ferring Pharmaceuticals A/S. The same ATC class is registered in 16 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Degarelix is registered in 16 of 19 countries.
Countries holding a registration under ATC L02BX02 (degarelix), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 10 of them publish a price we can compare per daily dose
Degarelix · ATC L02BX02
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of degarelix costs, country by country.
Normalised to the WHO defined daily dose (2.7 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Degarelix · price per daily dose (2.7 mg)
USD · FX 28 Sept 2026
- CH Switzerland$4.90
The record
At a glance
FEST (Norway)- Active substance
- Degarelix
- Manufacturer
- Ferring Pharmaceuticals A/S
- Country
- Norway (NO)
- ATC code
- L02BX02
- ATC class
- Degarelix
- Defined daily dose
- 2.7 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_B695CA82-7F36-4931-BCD7-40724264BA02
- no_varenummer0402391NOK 1413.2
- gtin7640180262534
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
266 interactions on record for degarelix.
Graded by severity as the source publishes them — 71 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Degarelix · interactions on record
266 records
- 71 severe
- 192 moderate
- 3 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- QuinidineC01BA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Degarelix in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomDegarelix 80mg powder and solvent for solution for injection vialsA A H Pharmaceuticals Ltd
- IcelandDegarelix AccordAccord Healthcare S.L.U.
- PolandDegarelix AccordAccord Healthcare S.L.U.
- SwedenDegarelix Accord 80 mg Pulver och vätska till injektionsvätska, lösningAccord Healthcare S.L.U.
- SwitzerlandFirmagon
- SpainFIRMAGON 80 mg POLVO Y DISOLVENTE PARA SOLUCION INYECTABLEFerring Pharmaceuticals A/S
- BelgiumFirmagon 80 mgFerring Pharmaceuticals
- FinlandDegarelix AccordAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Degarelix Accord, Firmagon
- Liechtenstein · Degarelix Accord, Firmagon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/59a038b5-2e4d-4c1b-91ac-1cc21af81bbb GET /v1/drugs/59a038b5-2e4d-4c1b-91ac-1cc21af81bbb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pulver og væske til injeksjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Degareliks",
"merkevare_id": "ID_B695CA82-7F36-4931-BCD7-40724264BA02",
"name_form_strength": "Firmagon pulv+væske til inj oppl 80 mg",
"prescription_group": "C"
}See everything about degarelix.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.